&w=3840&q=100)
Gland Pharma stock volatile after announcing Q4 results, dividend; Details
Gland Pharma share price slipped 2 per cent in the morning deals, however, its losses reversed and the stock was trading 4.9 per cent higher on BSE. The volatility in the stock came after the company reported its Q4 results.
At 9:55 AM, Gland Pharma shares were up 4.14 per cent at ₹1,558 per share on the BSE. In comparison, the BSE Sensex was up 0.66 per cent at 81,721.26. The market capitalisation of the company stood at ₹25,669.05 crore. The 52-week high of the stock was at ₹2,220.95 per share and the 52-week low of the stock was at ₹1,200 per share.
Gland Pharma Q4 results 2025
The company announced its fourth quarter (Q4FY25) results on May 20, 2025, after market hours. The company's consolidated net profit after tax (PAT) stood at ₹186.5 crore as compared to ₹192.4crore a year ago, down 3 per cent year-on-year (Y-o-Y).
Its revenue from operations also slipped 7 per cent at ₹1,424.9 crore for Q4 against ₹1,537.5 crore a year ago. Its Earnings before interest, tax, depreciation, and amortisation (Ebitda) stood at ₹347.5 crore as compared to ₹358.7 crore a year ago. The Ebitda margin for the quarter came in at 24 per cent against 23 per cent Y-o-Y.
According to the filing, research and development (R&D) expenses were ₹50.3 crore in Q4 FY25, representing 4.9 per cent of revenue, while for FY25 were ₹192.2 crore (4.7 per cent of revenue).
The company launched four new molecules, including Latanoprost, Midazolam Bags RTU, Dexamethasone, and Vancomycin (New Strengths), which were launched in Q4 FY25, contributing to 31 cumulative launches in FY25.
In the quarter under review, five Abbreviated New Drug Application (ANDAs) were filed and seven were approved, with a total of 24 ANDAs filed and 32 ANDAs approved in FY25, contributing to a cumulative total of 371 ANDA filings in the US (318 approved, 53 pending).
Gland Pharma dividend
The board of Gland Pharma recommended a final dividend of ₹18 per equity share for FY25, pending shareholder approval.
About Gland Pharma
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer [HK1] of small volume liquid parenteral products, to become one of the largest and fastest growing generic injectables manufacturing companies, with a global footprint across 60 countries, including the US, Europe, Canada, Australia, India and other markets.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
3 hours ago
- The Print
Stock markets rebound after 3-day fall; Sensex recovers 260 points
The 30-share BSE Sensex climbed 260.74 points, or 0.32 per cent, to settle at 80,998.25. During the day, it jumped 349.78 points, or 0.43 per cent, to 81,087.29. Market analysts said Indian equities closed with gains on better-than-expected US job market data and optimism over trade talks between the US and Chinese President this week also added optimism to markets recovery. Mumbai, Jun 4 (PTI) Indian benchmark equity indices Sensex and Nifty snapped the three-day losing streak and settled in the positive territory on Wednesday, mirroring a rally in global markets and supported by buying in blue-chips Reliance Industries and HDFC Bank. The NSE Nifty went up 77.70 points, or 0.32 per cent, to 24,620.20. From the Sensex firms, Eternal climbed 3.32 per cent. Bharti Airtel, IndusInd Bank, Tech Mahindra, Reliance Industries, Tata Motors, HDFC Bank, Tata Steel and Hindustan Unilever were the other major gainers. However, Bajaj Finserv, Axis Bank, Tata Consultancy Services, Titan and Larsen & Toubro were among the laggards. 'Indian equities closed with gains following positive global cues with Nifty-50 up 0.32 per cent at 24,620. US markets ended higher on Tuesday after better-than-expected April job openings data, indicating resilience in the US labour market despite concerns over tariff policies. 'Further, Asian indices ended in the positive on optimism over trade talks between the US and Chinese President this week,' Siddhartha Khemka, Head – Research, Wealth Management, Motilal Oswal Financial Services Ltd, said. The BSE midcap gauge jumped 0.76 per cent and smallcap index climbed 0.58 per cent. Among sectoral indices, telecommunication jumped 1.35 per cent, utilities (0.99 per cent), teck (0.75 per cent), energy (0.69 per cent), commodities (0.56 per cent), oil & gas (0.53 per cent) and metal (0.51 per cent). Bankex and realty were the laggards. As many as 2,071 stocks advanced while 1,933 declined and 151 remained unchanged on the BSE. 'We expect the market to remain in consolidation mode, tracking global markets and macro-economic cues; while stock-specific action would continue on the back of sectoral developments,' Khemka added. Global oil benchmark Brent crude jumped 0.14 per cent to USD 65.72 a barrel. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 2,853.83 crore on Tuesday, according to exchange data. On Tuesday, the 30-share BSE Sensex tanked 636.24 points, or 0.78 per cent, to settle at 80,737.51. The Nifty plunged 174.10 points, or 0.70 per cent, to 24,542.50. On the domestic macroeconomic front, the Indian services growth broadly steadied in May and was underpinned by healthy demand conditions, new client wins and greater staffing capacity. The seasonally adjusted HSBC India Services PMI Business Activity Index was at 58.8 in May, marginally up from April's 58.7 and signalled another sharp rate of expansion. PTI SUM DRR This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Economic Times
3 hours ago
- Economic Times
Choice International block deal: BNP Paribas sells shares worth Rs 78 crore in multibagger stock
French multinational bank and financial services company BNP Paribas on Wednesday sold 11 lakh shares in Choice International via a block deal which were worth Rs 78 crore while Societe Generale bought nearly as many shares. ADVERTISEMENT The shares of Choice International were bought and sold at a price of Rs 705.20 a piece which were on par with the Tuesday closing price. Today, the smallcap stock closed at Rs 704.55 on the NSE, down by Rs 0.65 or 0.09%. Prior to the block deal, BNP Paribas held 40,01,631 equity shares, representing 2% in the company as on March 31, 2025. The stock's market capitalisation is Rs 14,093 crore on the International is a diversified financial services company listed on both the NSE and BSE. Incorporated in 1992 and headquartered in Mumbai, the company operates across multiple segments, including broking and distribution, non-banking financial company (NBFC) services, and advisory of Choice International are trading above their 50-day and 200-day simple moving averages (SMAs) of Rs 604 and Rs 524 crore, respectively. The stock has been quite volatile and traded with a 1-year beta of 1.2 according to Trendlyne. ADVERTISEMENT Choice International is a multibagger stock with returns of 112% over the past one year while its year-to-date returns stand at 27%. It has outperformed Nifty whose returns in the same periods stand at 12% and 4%, company reported a consolidated net profit of Rs 54 crore in the quarter ended March 31, 2025 versus Rs 39 crore in the year ago period which is a 36% jump. As for the revenue, an 18% uptick was seen as the company reported a topline of Rs 255 crore in Q4FY25 versus Rs 216 crore in the corresponding quarter of the previous financial year. ADVERTISEMENT Also Read: Ola Electric block deal: Citigroup buys shares worth Rs 435 crore; Hyundai Motor, KIA sellers (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
3 hours ago
- Time of India
Choice International block deal: BNP Paribas sells shares worth Rs 78 crore in multibagger stock
Choice International share price: BNP Paribas offloaded 11 lakh shares of Choice International worth ₹78 crore in a block deal, with Societe Generale also selling nearly the same amount. Despite the sale, the stock remained steady, backed by strong fundamentals and solid FY25 earnings. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads French multinational bank and financial services company BNP Paribas on Wednesday sold 11 lakh shares in Choice International via a block deal which were worth Rs 78 crore while Societe Generale bought nearly as many shares of Choice International were bought and sold at a price of Rs 705.20 a piece which were on par with the Tuesday closing price. Today, the smallcap stock closed at Rs 704.55 on the NSE, down by Rs 0.65 or 0.09%.Prior to the block deal, BNP Paribas held 40,01,631 equity shares, representing 2% in the company as on March 31, stock's market capitalisation is Rs 14,093 crore on the International is a diversified financial services company listed on both the NSE and BSE. Incorporated in 1992 and headquartered in Mumbai, the company operates across multiple segments, including broking and distribution, non-banking financial company (NBFC) services, and advisory of Choice International are trading above their 50-day and 200-day simple moving averages (SMAs) of Rs 604 and Rs 524 crore, respectively. The stock has been quite volatile and traded with a 1-year beta of 1.2 according to International is a multibagger stock with returns of 112% over the past one year while its year-to-date returns stand at 27%. It has outperformed Nifty whose returns in the same periods stand at 12% and 4%, company reported a consolidated net profit of Rs 54 crore in the quarter ended March 31, 2025 versus Rs 39 crore in the year ago period which is a 36% jump. As for the revenue, an 18% uptick was seen as the company reported a topline of Rs 255 crore in Q4FY25 versus Rs 216 crore in the corresponding quarter of the previous financial Read: Ola Electric block deal: Citigroup buys shares worth Rs 435 crore; Hyundai Motor, KIA sellers
